Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
PURE Bioscience (PURE) had Return on Assets of -226.75% for the most recently reported fiscal year, ending 2025-07-31.
| Income Statement Financials | |
$2.20M |
|
$-2.40M |
|
$0.90M |
|
$1.30M |
|
$4.47M |
|
$-2.27M |
|
$-0.13M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.27M |
|
$-2.27M |
|
111.86M |
|
111.86M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.01M |
|
$0.01M |
|
$1.06M |
|
$0.94M |
|
$5.24M |
|
$5.24M |
|
$6.17M |
|
$-5.12M |
|
$-5.12M |
|
$-5.12M |
|
111.89M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
-- |
|
$2.00M |
|
$0.42M |
|
$0.41M |
|
$-0.01M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
43.63 |
|
-1.02 |
|
59.17% |
|
-103.18% |
|
-103.18% |
|
-103.09% |
|
-108.95% |
|
-108.95% |
|
$-2.02M |
|
-- |
|
-- |
|
-- |
|
2.08 |
|
6.38 |
|
4.65 |
|
78.57 |
|
46.89% |
|
46.89% |
|
|
Return on Assets |
-226.75% |
-1999.17% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|